Citadel Advisors’s Future Health ESG Corp. Unit FHLTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-107,323
Closed -$91.2K – 15895
2024
Q1
$91.2K Sell
107,323
-55
-0.1% -$587 ﹤0.01% 11480
2023
Q4
$36K Hold
107,378
– – ﹤0.01% 12106
2023
Q3
$49.9K Sell
107,378
-49
-0% -$503 ﹤0.01% 11765
2023
Q2
$36.5K Hold
107,427
– – ﹤0.01% 12148
2023
Q1
$103K Buy
107,427
+77
+0.1% +$766 ﹤0.01% 11222
2022
Q4
$97.9K Buy
107,350
+20
+0% +$203 ﹤0.01% 11251
2022
Q3
$241K Sell
107,330
-29
-0% -$293 ﹤0.01% 10037
2022
Q2
$241K Sell
107,359
-716
-0.7% -$7.17K ﹤0.01% 10297
2022
Q1
$133K Sell
108,075
-310,767
-74% -$3.11M ﹤0.01% 11990
2021
Q4
$3.24M Sell
418,842
-1,249,404
-75% -$12.5M ﹤0.01% 5187
2021
Q3
$15.9M Buy
+1,668,246
New +$16.6M ﹤0.01% 2344

Citadel Advisors's FHLTU Position: Q2 2024 in Review

Citadel Advisors sold out of Future Health ESG Corp. Unit (FHLTU) in Q2 2024, closing a stake of 107,323 shares — an estimated $91.2K sold.

Citadel Advisors first reported a position in FHLTU in Q3 2021 and held it in 11 quarters. The position peaked at $15.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold FHLTU as of Q2 2024.

  • Citadel Advisors reported no remaining Future Health ESG Corp. Unit position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 107,323 Future Health ESG Corp. Unit shares in Q2 2024, an estimated $91.2K.
  • Citadel Advisors first reported a position in Future Health ESG Corp. Unit in Q3 2021 and held it in 11 quarters.
  • Citadel Advisors's Future Health ESG Corp. Unit position peaked at $15.9M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Future Health ESG Corp. Unit as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.